SEARCH

SEARCH BY CITATION

References

  • BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248254.
  • BRUINVELS, A.T., LERY, H., NOZULAK, J., PALACIOS, J.M. & HOYER, D. (1992). 5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 243248.
  • DAVIDSON, C., HO, M., PRICE, G.W., JONES, B.J. & STAMFORD, J.A. (1997). (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors. Br. J. Pharmacol., 121, 737742.
  • FEUERSTEIN, T.J., HÜRING, H., VAN VELTHOVEN, V., LÜCKING, C.H. & LANWEHRMEYER, G.B. (1996). 5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex. Neurosci. Lett., 209, 210214.
  • FINK, K., ZENTNER, J. & GÖTHERT, M. (1995). Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1Dβ receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 451454.
  • FLETCHER, A., BILL, D.J., BILL, S.J., CLIFFE, I.A., DOVER, G.M., FORSTER, E.A., HASKINS, J.T., JONES, D., MANSELL, H.L. & REILLY, Y. (1993). WAY 100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur. J. Pharmacol., 237, 283291.
  • GALZIN, A.M., POIRIER, M.F., LISTA, A., CHODKIEWICZ, J.P., BLIER, P., RAMDINE, R., LOÔ, H., ROUX, F.X., REDONDO, A. & LANGER, S.Z. (1992). Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex. J. Neurochem., 59, 12931301.
  • GASTER, L.M., BLANEY, F.E., DAVIES, S., DUCKWORTH, D.M., HAM, P., JENKINS, S., JENNINGS, A.J., JOINER, G.F., KING, F.D., MULHOLLAND, K.R., WYMAN, P.A., HAGAN, J.J., HATCHER, J., JONES, B.J., MIDDLEMISS, D.N., PRICE, G.W., RILEY, G., ROBERTS, C., ROUTLEDGE, C., SELKIRK, J. & SLADE, P.D. (1998). The selective 5-HT1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J. Med. Chem., 41, 12181235.
  • HAMBLIN, M.W. & METCALF, M.A. (1991). Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol. Pharmacol., 40, 143148.
  • HARTIG, P.R., BRANCHEK, T.A. & WEINSHANK, R.L. (1992). A subfamily of 5-HT1D receptor genes. Trends Pharmacol. Sci., 13, 152159.
  • HOYER, D. & BODDEKE, H.W.G.M. (1993). Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. Sci., 14, 270275.
  • HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 2, 157203.
  • KAUMANN, A.J., FRENKEN, M., POSIVAL, H. & BROWN, A.M. (1994). Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. Circulation, 90, 11411153.
  • MARTIN, G.R. & HUMPHREY, P.P.A. (1994). Classification Review. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261273.
  • MAURA, G., MARCOLI, M., TORTAROLO, M., ANDRIOLI, G.C. & RAITERI, M. (1998). Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h5-HT1D receptors. Br. J. Pharmacol., 123, 4550.
  • MAURA, G., THELLUNG, S., ANDRIOLI, G.C., RUELLE, A. & RAITERI, M. (1993). Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex. J. Neurochem., 60, 11791182.
  • MOLDERINGS, G.J., FRÖLICH, D., LIKUNGU, J. & GÖTHERT, M. (1996). Inhibition of noradrenaline release via presynaptic 5-HT1Dα receptors in human atrium. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 272280.
  • PAUWELS, P.J. & COLPAERT, F.C. (1995). The 5-HT1D receptor antagonist GR 127,935 is an agonist at cloned human 5-HT1Dα receptor sites. Neuropharmacology, 34, 235237.
  • PAUWELS, P.J., PALMIER, C., WURCH, T. & COLPAERT, F.C. (1996). Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 144156.
  • PAUWELS, P.J., TARDIF, S., PALMIER, C., WURCH, T. & COLPAERT, F.C. (1997). How efficacious are 5-HT1B/D receptor ligands: an answer from GTPγS binding studies with stably transfected C6-glial cell lines. Neuropharmacology, 36, 499512.
  • PRICE, G.W., BURTON, M.J., COLLIN, L.J., DUCKWORTH, M., GASTER, L., GÖTHERT, M., JONES, B.J., ROBERTS, C., WATSON, J.M. & MIDDLEMISS, D.N. (1997). SB-216641 and BRL-15572-compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 312320.
  • RAITERI, M. (1994). Functional studies of neurotransmitter receptors in human brain. Life Sci., 54, 16351647.
  • RAITERI, M., ANGELINI, F. & LEVI, G. (1974). A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol., 25, 411414.
  • ROBERTS, C., BELENGUER, A., MIDDLEMISS, D.N. & ROUTLEDGE, C. (1998). Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. Eur. J. Pharmacol., 346, 175180.
  • ROBERTS, C., PRICE, G.W., GASTER, L., JONES, B.J., MIDDLEMISS, D.N. & ROUTLEDGE, C. (1997). Importance of 5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig. Neuropharmacology, 36, 549557.
  • SCHLICKER, E., BRANDT, F., CLASSEN, K. & GÖTHERT, M. (1985). Serotonin release in human cerebral cortex and its modulation via serotonin receptors. Brain Res., 331, 337341.
  • SCHLICKER, E., FINK, K., MOLDERINGS, G.J., PRICE, G.W., DUCKWORTH, M., GASTER, L., MIDDLEMISS, D.N., ZENTNER, J., LIKUNGU, J. & GÖTHERT, M. (1997). Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 321327.
  • SKINGLE, M., BEATTIE, D.T., SCOPES, D.I.C., STARKEY, S.J., CONNOR, H.E., FENIUK, W. & TYERS, M.B. (1996). GR127935: a potent and selective 5-HT1D receptor antagonist. Behav. Brain Res., 73, 157161.
  • SKINGLE, M., SCOPES, D.I.C., FENIUK, W., CONNOR, H.E., CARTER, M.C., CLITHEROW, J.W. & TYERS, M.B. (1993). GR 127935: a potent orally active 5-HT1D receptor antagonist. Br. J. Pharmacol., 110, 9P.
  • TONNAER, J.A.D.M., ENGELS, G.M.H., WIEGANT, V.M., BURBACH, J.P.H., DE JONG, W. & DE WIED, D. (1983). Proteolytic conversion of angiotensins in rat brain tissue. Eur. J. Biochem., 131, 415421.
  • WALSH, D.M., BEATTIE, D.T. & CONNOR, H.E. (1995). The activity of 5-HT1D receptor ligands at cloned human 5-HT1Dα and 5-HT1Dβ receptors. Eur. J. Pharmacol., 287, 7984.
  • WATSON, J.M., BURTON, M.J., PRICE, G.W., JONES, B.J. & MIDDLEMISS, D.N. (1996). GR127935 acts as a partial agonist at recombinant human 5-HT1Dα and 5-HT1Dβ receptors. Eur. J. Pharmacol., 314, 365372.
  • WEINSHANK, R.L., ZGOMBICK, J.M., MACCHI, M.J., BRANCHEK, T.A. & HARTIG, P.R. (1992). Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ Proc. Natl. Acad. Sci. U.S.A., 89, 36303634.
  • ZGOMBICK, J.M., BARD, J.A., KUCHAREWICZ, S.A., URQUHART, D.A., WEINSHANK, R.L. & BRANCHEK, T.A. (1997). Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors. Neuropharmacology, 36, 513524.
  • ZGOMBICK, J.M., SCHECHTER, L.E., ADHAM, N., KUCHAREWICZ, S.A., WEINSHANK, R.L. & BRANCHEK, T.A. (1996). Pharmacological characterizations of recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 226236.
  • ZGOMBICK, J.M., SCHECHTER, L.E., KUCHAREWICZ, S.A., WEINSHANK, R.L. & BRANCHEK, T.A. (1995). Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes. Eur. J. Pharmacol. Mol. Pharmacol. Section, 291, 915.